June 15, 2021

Salk Institute receives Charity Navigator’s highest rating for tenth consecutive time

Honor recognizes Institute’s commitment to fiscal transparency and accountability

Salk Nachrichten


Salk Institute receives Charity Navigator’s highest rating for tenth consecutive time

Honor recognizes Institute’s commitment to fiscal transparency and accountability

LA JOLLA—For the tenth consecutive time, the Salk Institute has earned the highest ranking—4 out of 4 stars—from Charity Navigator, America’s largest independent charity and nonprofit evaluator. Only three percent of the roughly 10,000 nonprofits evaluated have achieved this recognition ten consecutive times. The coveted ranking indicates the Salk Institute has demonstrated strong financial health and commitment to accountability and transparency, outperforming most other charities in America in regard to executing best fiscal practices and carrying out its mission in a financially efficient way.

“This recognition by Charity Navigator of Salk’s continued success achieving the highest level of fiscal accountability and transparency among our peers is exciting and something we are proud to receive once again,” says Salk Institute President Rusty Gage.

4starsquarebw

Charity Navigator’s data-driven analysis of the 1.5 million American charities has been covered by Forbes, Business Week and others for providing donors with a way to recognize nonprofits that provide greater accountability, transparency and concrete results.

“Our donors showed their faithful support of Salk science through an uncertain year, as our scientists and the world worked through the many challenges presented by a global pandemic,” says Rebecca Newman, Salk’s vice president of External Relations. “We are deeply gratified that the Charity Navigator rankings reflect our donors’ confidence in the Institute’s stewardship and trustworthiness.”

Since receiving its previous rating from Charity Navigator in 2019, the Salk Institute has made bold progress in pursuing ambitious solutions to the difficult challenges facing humanity, including climate change, aging and cancer.

Support for these initiatives included gifts of $30 million from the Bezos Earth Fund and $12.5 million from Hess Corporation, both in support of Salk’s Initiative zur Nutzung von Pflanzen. This scalable approach to help humanity deal with a warming planet aims to optimize plants to store more carbon and adapt to diverse climate conditions.

In addition, the NOMIS Foundation gave $9.5 million to Salk’s NOMIS Center for Immunobiology and Microbial Pathogenesis to grow and expand, while the center continues to be a leader in health and immunity research.

The Institute continues to make bold progress through its Initiative zur Überwindung von Krebs, which seeks to tackle six deadly cancers: colon, pancreatic, ovarian, lung, glioblastoma and triple-negative breast.

“I wish to congratulate Salk Institute for Biological Studies on attaining the coveted 4-star rating ten consecutive times. This designation sets Salk apart from its peers and demonstrates to the public its trustworthiness,” says Michael Thatcher, President and CEO of Charity Navigator.

Since 2002, Charity Navigator has used objective analysis to award only the most fiscally responsible organizations a 4-star rating: only a quarter of charities rated receive this distinction. In 2011, Charity Navigator added 17 metrics, focused on governance and ethical practices as well as measures of openness, to its ratings methodology. These Accountability and Transparency metrics, which account for 50 percent of a charity’s overall rating, reveal which charities operate in accordance with industry best practices and whether they are open with their donors and stakeholders.

Für weitere Informationen

Büro für Kommunikation
Telefon: (858) 453-4100
press@salk.edu

Das Salk-Institut für biologische Studien:

Das Salk Institute ist ein unabhängiges, gemeinnütziges Forschungsinstitut, das 1960 von Jonas Salk, dem Entwickler des ersten sicheren und wirksamen Polio-Impfstoffs, gegründet wurde. Die Aufgabe des Instituts besteht darin, grundlegende, kooperative und risikofreudige Forschung voranzutreiben, die sich mit den dringendsten Herausforderungen der Gesellschaft befasst, darunter Krebs, Alzheimer und die Gefährdung der Landwirtschaft. Diese Grundlagenforschung bildet die Basis für alle translationalen Bemühungen und führt zu Erkenntnissen, die neue Medikamente und Innovationen weltweit ermöglichen.